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Summary A trophoblast cell surface antigen has been characterised by a monoclonal antibody (mAb) 5T4,
raised following immunisation with solubilised wheat germ agglutinin binding glycoproteins from human
syncytiotrophoblast plasma membrane (StMPM). The expression of the 72 kDa glycoprotein was assessed on
cryostat sections of a range of neoplastic and non-neoplastic tissues, using an avidin-biotin immunoperoxidase
technique. In products of conception, intense reactions were noted with villous syncytiotrophoblast membrane
in normal early and term placenta, with weaker positivity of placental site trophoblast. Most normal or
non-neoplastic tissues were negative, including liver, kidney, spleen, small intestine, ovary and testis. Faint or
moderate positive reactions were present in some specialised epithelia. Of 115 neoplasms examined, 76 showed
reactions with tumour cells including carcinomas of the bladder, breast, cervix, endometrium, lung,
oesophagus, ovary, pancreas, stomach and testicular non-seminomatous germ cell tumours. Choriocarcinomas
and placental site trophoblastic tumours were also positive. Most adenocarcinomas of colon and seminomas
were negative as were all malignant melanomas and malignant lymphomas. A radioimmunoassay did not
detect the antigen in either normal or pregnancy serum. The relatively low level ofexpression in normal tissues
and reactivity with a wide range of carcinomas suggested that the antibody may be useful in diagnostic or
targeting studies.
5T4 (mAb) recognises a trophoblast glycoprotein of 72 kDa
which is also expressed by many carcinoma tumour cell lines
(Hole & Stern, 1988). Previous studies have suggested a
relatively restricted normal adult tissue distribution. Uisng a
semi-quantitative immunodot assay, brain, muscle, kidney,
liver, ovary and testes were shown to express at least 1,000-
fold less 5T4 antigen than term placenta. Several previously
described trophoblast and/or fetal antigens show a similar
pattern of expression by transformed cell lines to 5T4
antigenic molecules (Johnson, 1984). In some cases there is
trophoblast antigen expression by tumour cell lines derived
from antigen negative tissues. This may reflect the inapprop-
riate expression of a trophoblast molecule, for example hCG
is expressed by some tumours of breast, intestinal and
ovarian origins (Vaitukakis, 1979). Alternatively, minor sub-
populations of cells within 'negative' normal tissues may
express 5T4 antigenic molecules; hence expression by some,
but not all, transformed cell lines could simply reflect a
clonal expansion of this putative sub-population of 5T4
antigen positive cells.
Trophoblast antigen expression may also result from the
adaptation of some cell lines to in vitro culture; for example,
despite an absence of PLAP expression by amniotic
epithelium, the amnion cell line AV-3 has been shown to
express the antigen (McLaughlin et al., 1982). The most
interesting possibility is that 5T4 antigen expression by
tumour cell lines follows transformation to the neoplastic
phenotype. If this is the case, then a variety of neoplastic
tumour tissues should be antigen positive. Together with a
relatively restricted normal tissue antigen distribution, the
5T4 antibody would be potentially useful in diagnosis,
tumour localisation and drug targeting (Baldwin & Byers,
1987). This study evaluates the distribution of the antigen
recognised by mAb 5T4 in normal and neoplastic tissues by
immunohistochemistry.
Materials and methods
Immunohisitochemistry
A panel of normal, non-neoplastic and neoplastic tissues
were used. Fresh tissue samples were frozen in iso-pentane,
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previously cooled in liquid nitrogen, 6jim thick cryostat
sections were cut, air dried for 10 min and then fixed in
acetone. An avidin-biotin immunoperoxidase technique was
employed for the screening of the hybridoma culture super-
natant 5T4.
Specifically, sections were washed in two changes of tris
buffered saline (TBS) pH 7.6 and then covered with 10%
normal horse serum in TBS for 20 min. After draining, the
slides were incubated with neat culture supernatant for
30 min in a moist chamber. Following three washes in TBS
(5 min each), biotinylated anti-mouse Ig (Vector
Laboratories) diluted 1/250 in TBS containing 10% normal
human serum was applied. After 30 min incubation in the
moist chamber, the slides were washed three times and
incubated with the avidin-biotin peroxidase complexes rea-
gent (Vector Laboratories) for 50 min. After three washes in
TBS, peroxidase was visualised using a freshly prepared and
filtered solution of diaminobenzidine tetrahydrochloride
(DAB-Sigma) in TBS containing 0.03% hydrogen peroxide
(6 min). Sections were washed in tap water and counter-
stained in Coles' haematoxylin, dehydrated, cleared and
mounted (Ralmount-R.A. Lamb). The immunohistochemical
results were interpreted with reference to a set ofcontrols run
in parallel with each test. These included sections treated
with DAB only to show endogenous peroxidase, omission of
the primary antibody and replacement of the primary
antibody with one of the same class but of unrelated
specificity. Reactivity of mAb 5T4 with fixed and paraffin
wax embedded sections of term placental trophoblast was
also assessed by immunoperoxidase. 5T4 mAb reactivity was
assessed by P.J.S. and G.M.B. and the intensity of staining
was scored on an arbitrary scale ( + to + + + ). Very weak
or equivocal reactions were scored + /-.
Flow cytometric analyses of human bone marrow cells
labelled in PBS, 1% BSA 0.1% azide with 5T4 mAb followed
by 1/20 rabbit anti-mouse Ig-FITC (Serotec, Bicester, UK)
was performed on a Becton-Dickenson FACS analyser. The
purified mAb 5T4 at 10 ig ml-' was tested for interference
with the growth of human pluripotential haematopoietic col-
onies as described by Welte et al. (1985).
Radioimmunoassay
Syncytiotrophoblast microvillous plasma membranes
(StMPM) were prepared as previously described (Hole &
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Stern, 1988) and were solubilised in 1% deoxycholate (DOC)
in tris buffer saline pH 8.0 at a concentration of 3.5 mg ml-'.
5T4 mAb was purified from 1 litre of tissue culture super-
natant as follows. The proteins were concentrated by 50%
saturated ammonium sulphate precipitation and extensively
dialysed, versus 3M NaCl, 1.5 M glycine pH 8.9. This was
filtered through a 0.45 jim millipore membrane and 50 ml
loaded onto a protein A sepharose column (2 ml). The col-
umn was washed with loading buffer and 5T4 IgGI
antibodies eluted with 10 ml of 100 mM citrate buffer pH 6.
Ninety per cent of the 5T4 activity as measured by ELISA
was recovered. DOC-solubilised membranes were diluted to
25 jLg ml' in 0.1 M carbonate buffer pH 9.6 and 100 jil
added per well of a Dynatech microtitre plate. This was
incubated overnight at room temperature and the plates were
then washed three times with 0.05% Tween PBS (phosphate
buffered saline, Dulbecco's PBS-A, Oxoid). In another mic-
rotitre plate, duplicate doubling dilutions of sera or sera plus
DOC-solubilised membranes diluted in 0.1% Tween-PBS
were made in 60 jil volumes. Six hundred ng of purified IgGI
5T4 mAb was labelled with '251, using Biorad insolubilised
lactoperoxidase-glucose oxidase beads as described by the
manufacturers (BioRad, Richmond, CA, USA). The labelled
antibody had specific activity of I05 c.p.m. ng-' and approx-
imately 104 c.p.m. in 60 jil was added per well to the dilutions
of soluble test antigens. One hundred jIl of this mixture was
added to the washed StMPM antigen coated plates and then
incubated at 4°C overnight. The plates were then washed
three times with 0.05% Tween-PBS and counts bound to the
plates solubilised by incubating in 0.2 M NaOH for I h at
37°C. The counts were measured in a Wallac gamma counter.
Results
Immunohistochemistry
The distribution of positive reactions with mAb 5T4 in nor-
mal and non-neoplastic tissues is summarised in Table I. The
villous syncytiotrophoblast from first and third trimester
placentae (Figure la, b) and ectopic tubal pregnancy showed
strong membrane positivity. Placental site trophoblast dis-
played both membrane and cytoplasmic reactions. Villous
cytotrophoblast, the stroma of chorionic villi and fetal blood
vessels were negative.
In the non-neoplastic tissues examined, weak or moderate
reactions were found in the basal layer of stratified squamous
epithelium (cervix, oesophagus and skin), glandular
epithelium of endocervix and endometrium, mucosal glands
of stomach and large intestine and some excretory ductal
epithelium of pancreas. All components of normal brain,
liver (Figure lc), small intestine, ovary, testis or lymphoid
tissues were unreactive with mAb 5T4. Occasional reactivity
with elements in some normal tissues are noted in Table I.
Flow cytometry analysis of bone marrow cell populations
indicated no reactive cells and the antibody did not interfere
with the development of haemopoietic precursor colonies in
culture (data not shown).
Table II summarises the distribution of mAb 5T4 labelling
in neoplastic tissues. Many malignant epithelial tumours dis-
played positive reactions: of note, were carcinomas of blad-
der (4/4), breast (5/5), cervix (5/5), lung (8/8) including four
squamous cell carcinomas, stomach (6/7) and pancreas in-
cluding one of the ampulla of Vater (4/4). Figure 2 illustrates
immunohistochemistry of squamous carcinoma of the lung
and cervix, invasive ductal adenocarcinoma of the breast and
adenocarcinoma of the endometrium. One of three neuro-
blastomas showed significant 5T4 expression associated with
both membrane and cytoplasm as did a single apendyoma: a
glioblastoma multiforme was negative. The majority of col-
onic adenocarcinomas were negative, positivity in 3/12 was
confined to only a few tumour cells and was weak. Cyst-
adenocarcinomas of the ovary produced variable reactions; in
3/4 positive cases, the majority of tumour cells were positive
and in the other the majority were negative. In the testes all
a
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Figure 1 Avidin-biotin peroxidase staining of 5T4 mAb in cryo-
stat sections of (a) first trimester placenta, showing labelling of
the syncytiotrophoblast layer ( x 60); (b) term placenta showing
syncytiotrophoblast positivity of the membrane and cytoplasm
( x 96); (c) adult liver-negative; and (d) fetal colon-epithelium
negative but with faintly positive endothelium in villous stroma
( x 96).
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Table I Results of immunohistochemical distributions of monoclonal antibody 5T4 in non-neoplastic tissues
Number Intensity
Tissue/organ Morphology positive ofreaction Distribution/comments
Brain Normal 0/1
Cervicitis/squamous metaplasia
Normal and one non-neoplastic
from a case of choriocarcinoma
Normal and non-neoplastic mucosa
4/4 + Endocervical glands positive in 3/4 and basal layer
of squamous epithelium in 2/3 (squamous
epithelium not present in one case)
1/2 + / + + Endometrial glands positive from case of
choriocarcinoma and negative in normal
pregnancy. Endometrial stroma and myometrium
negative
3/6 + / - Mucous secreting epithelium weakly positive and
some constituents of lamina propria
Intestine (small)
Fetal intestine
Kidney
Normal
Normal
Non-neoplastic
0/1
0/1
0/2
Epithelium negative, but weak binding to
endothelium in villous stroma
Tubules negative but weak + / - of endothelial
cells in glomeruli present in one case
Liver
Lung
Lymph node
Oesophagus
Ovary
Pancreas
Prostate
Seminal vesicles
Skin
Spleen
Stomach
Tonsil
Testis
Non-neoplastic
Non-neoplastic (from primary
tumour cases)
Non-neoplastic (from metastatic
choriocarcinoma cases)
Non-specific reactive changes
Non-neoplastic
Non-neoplastic (including corpus
luteum, corpore albicontra and
stroma)
Normal and non-neoplastic
Hyperplastic
Normal
Normal epidermis
Non-specific reactive changes
Non-neoplastic mucosa
Normal
Non-neoplastic
0/4
3/7 + / + + Three specimens showed some focal staining of
cuboidal cells lining a bronchiola
0/5
1/1
3/3
0/4
3/3
1/1
1/1
2/2
0/4
2/4
1/1
0/2
In one case reactivity, but it was difficult to assess
whether positive cells are type-lI pneumocytes,
alveolar lining cells or degenerate tumour
+ /- Clusters of cells in sinusoids faintly positive,
probably histiocytes and endothelial cells
+ Basal layer of stratified squamous epithelium
positive
Almost all negative apart from faint focal + -of
stromal cells. Surface epithelium and follicles not
seen
+ Focal, faint reaction in small collecting duct
cuboidal epithelium and mucous secreting
epithelium
+ /- Focal reactivity of glandular epithelium most
negative
+ / - Faint focal reaction of epithelium
+ Faint, focal reaction of basal layer of stratified
squamous epithelium
White pulp negative. Two show faintly positive
vascular endothelium in red pulp
+ Mucous glands weakly positive in two cases
+ Lymphocytes negative. Weak reaction with basal
epithelium and endothelial cells
Seminiferous tubules, spermatogonia, mature
sperms, Sertoli cells, Leydig cells are negative
Non-neoplastic
Non-neoplastic
0/1
1/1
Placenta (first trimester)
Ectopic pregnancy
Placenta (term)
+ /
- Focal reaction of cells lining follicles. Colloid
negative
5/5 + / +++ Syncytiotrophoblast + / + + + Cytotrophoblast
and fetal vessels negative
2/2 + + + Strong reaction of syncytiotrophoblast with
weaker labelling of placental site trophoblast.
Stroma of chorionic villi negative
5/5 + / +++ Syncytiotrophoblast strongly positive
classical seminomas were negative. In one case of seminoma,
reactivity was present in syncytiotrophoblast-like giant cells
and embryonal carcinoma cells. All anaplastic germ cell
tumours of the testis showed variable positive reactions.
Where syncytiotrophoblast was present, this was strongly
positive. Generally embryonal carcinoma and yolk sac struc-
tures were only faintly positive. This ranged from the
majority of tumour cells being positive (one case) to a
minority (one case). It was unclear whether undifferentiated
mesenchyme showed significant reactivity above the level
seen in control sections. The cystic epithelium of mature
teratomas often displayed a focal weak to moderate reaction.
Syncytiotrophoblast of choriocarcinomas and a complete
hydatidiform mole was strongly positive (Figure 3a, b).
Much of the trophoblast of placental site tumours showed
moderate or strong labelling on both cell membranes and
within the cytoplasm (Figure 3c). In examples of fibrosar-
coma and leiomyosarcoma most tumour cells were negative,
with some focal and weak reactions in a few cells, but a
sarcoma from the soft part of the alveolus exhibited general-
ised cytoplasmic reactivity. Malignant melanomas (five) and
malignant lymphomas (three) were negative.
Cervix
Endometrium
Intestine (large)
Thymus (fetal)
Thyroid gland
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Table 11 Results of immunohistochemical distribution of monoclonal antibody 5T4 in neoplastic tissues
Number Intensity
Tissue/organ Morphology positive ofreaction Distribution/comments
Ampulla of Vater Invasive adenocarcinoma 1/1 + + + Focal reaction of tumour acini, membrane and
Squamous cell carcinoma
Apendyoma
Glioblastoma multiforme
Neuroblastoma
Invasive carcinoma
Squamous carcinoma (invasive)
Invasive adenocarcinoma
Tubulovillous adenoma
Adenocarcinoma (invasive)
Malignant, mixed Mullerian tumour
Clear cell adenocarcinoma
Renal carcinoma
Metastatic carcinoid tumour
Squamous carcinoma
Bronchioalveolar carcinoma
Large cell (undifferentiated)
Giant cell carcinoma
Alveolar soft part sarcoma
Metastatic (leiomyosarcoma)
Lymphoma (non-Hodgkin's, large
bowel one case)
Squamous carcinoma
Cystadenocarcinomas various
(including, serous x 2, mucinous
x I and a metastatic ovarian
carcinoma in a lymph node)
Brenner tumour (in mucinous
cystadenoma)
Granulosa cell tumour
Cystadenoma
Teratoma (solid)
Adenocarcinoma (invasive)
Basal cell carcinoma
Malignant melanoma
Fibrosarcoma
cytoplasm
4/4 + / +++ Tumour cells show membrane and cytoplasmic
labelling. In one tumour specimen, many cells
negative
1/1 + / + ++ Tumour cells show both membrane and
0/1 cytoplasmic reactivity
1/3 +
5/5 +/ + + + Membrane and cytoplasmic reactions of tumour
cells. Occasional ± of stromal elements.
5/5 + + + Cytoplasmic and membrane positivity of most
tumour cell. Endocervical glands + + / + + +
Stromal cells + +
3/12 + Focal reactivity of a few tumour cells only. Weak
+ / - of stroma and non-neoplastic large bowel
glands
1/1 + + Mainly membrane (mucosal surface) with some
cytoplasmic reactivity
2/2 + / +++ Generalised positivity of carcinoma cells, both
membrane and cytoplasm. Small groups of cells
+ + + on membrane, focal + + reactivity of
undifferentiated and mutinucleate cells
1/1 + / +++ Focal, mainly cytoplasmic. Large clumps of
tumour cells negative
1/1 + + Focal membrane and cytoplasmic reaction
0/2
0/1
4/4
1/1
2/2
1/1
1/1
1/1
+ / + + Most tumour cells positive, membrane and
cytoplasm
+ Most tumour cells positive, cytoplasmic reactions
+ Most tumour cells positive, membrane and
cytoplasm. Patchy positivity of stroma
surrounding tumour
+ ++ Membrane reaction of most cells
+ / + + Generalised reactivity, mainly cytoplasmic
+ Focal, membrane and cytoplasm of tumour cells.
Collagenised stroma positive
0/3
2/2 + / + + Focal, most tumour cells negative in one
specimen. Generalised membrane and cytoplasmic
labelling in other
4/7 + + / + + + In positive tumours both membrane and
cytoplasmic reactivity. In three cases most tumour
cells positive. 5% tumour cells positive in one
case. Negative tumours-serous papillary ( x 1),
mucinous ( x 1), poorly differentiated ( x 1)
1/1 + Clusters of cells in Brenner tumour positive
cytoplasmically
0/1
0/3 Weak + /-of mucin
1/1 -/ +++ Basal layer of squamous epithelium + /-,
respiratory epithelium +, focal reaction of mucin
secreting cells. Mesenchyme and chondrocytes +,
acini + +/+ + +
3/3 + / + + Focal, mainly cytoplasmic reaction with little
membrane positivity. Many tumour cells negative.
Stroma + / + +
0/1
0/5
1/1 +
Bladder
Brain
Breast
Cervix
Colon
Endometrium
Kidney
Liver
Lung
Lung
Lung
Lymph node
Oesophagus
Ovary
Ovary
Pancreas
Skin
Soft tissue5T4 ANTIGEN AS A TUMOUR MARKER 93
Table II-continued
Number Intensity
Tissue/organ Morphology positive ofreaction Distribution/comments
Stomach Adenocarcinomas (invasive) 6/7 + / + + Membrane and cytoplasm of tumour cells positive.
Variable reaction of non-neoplastic gastric mucosa
- / + + . Extracellular mucin positive in two
cases. Stromal elements -/ + +. Rarely cells in
lamina propria positive.
Testis Seminoma 1/5 + / + + Focal reaction of tumour cells in one case with
syncytiotrophoblast giant cells and embryonal
carcinoma faintly positive
Testis Mature cystic teratoma (in testis) 3/4 + / + + Focal reaction of basal layer of stratified
squamous epithelium and columnar epithelium.
Mucin mesenchyme weakly positive
Mature cystic teratoma (metastatic 0/3
from testis in lung)
Anaplastic germ cell tumour 7/7 + / + + + Trophoblast + + +, embryonal
including metastases x 3, MTI x 3 carcinoma/yolk-sac tumour + . Undifferentiated
(one is metastatic) tumour + + . The reactivity is variable in some
tumours many negative cells
Thyroid Adenocarcinoma (metastatic to 0/1
thyroid)
Trophoblast Choriocarcinoma ( x 4 in uterus, 7/7 + / + + + Syncytiotrophoblast + + / + + +,
x I in lung, x 2 in brain) Cytotrophoblast + / + + (3 cases) show
membrane and cytoplasmic reactivity
Placental site trophoblastic tumour 2/2 + + / + + + Most tumour cells positive
(membrane predominantly)
Hydatidiform mole 1/1 + / +++ Syncytiotrophoblast + + + (membrane)
Cytotrophoblast faintly positive. Stroma of
chorionic villi negative
The stroma of some tumours showed weak and focal
reactions. This was also noted in the endothelium lining some
small blood vessels in many tissues and tumours (see fetal
colon, Figure Id).
The cellular location of binding with mAb 5T4 in tumours
is either membranous or cytoplasmic or a combination of
both. Heavy membrane-bound location is a particular feature
of syncytiotrophoblast. Cytoplasmic reactivity was
predominant in pancreatic carcinomas. In gastric and breast
carcinomas, both types of pattern were present. MAb 5T4
was unreactive with fixed and paraffin wax embedded tissue
sections of villous trophoblast of term placentae.
Radioimmunoassay
Figure 4 illustrates an example of an assay for soluble
antigen in human serum. '251-labelled purified 5T4 mAb is
bound to microtitre plates with bound solubilised StMPM
and competed by the latter or serum. The sensitivity of this
assay for 5T4 antigen is 0.1 ng ml-' (see Discussion). No
significant 5T4 antigen was detected in serum diluted 1/100
compared with normal goat serum similarly diluted. This
assay establishes that the 5T4 antigen in normal serum must
be less than 10 ng ml-'. Assays on seven normal non-
pregnant sera, five first trimester, eight third trimester and
eight post-partum sera gave similar results.
Discussion
Mab 5T4 gives reactions in trophoblast which are similar to
other antitrophoblast antibodies. However, our detailed
immunohistochemical and previous biochemical analysis
(Hole & Stern, 1988) shows that the antigen recognised is
novel and distinct from the Psubunit of HCG or recently
reported urinary gonadotrophin peptide (UGP) (Kardana et
al., 1988), PLAP (Johnson, 1984), trophoblast-leukocyte
common antigen (Stern et al., 1986) and those which react
with mAb 18A/C4 and 18B/A5 (Loke et al., 1986). Some of
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Figure 4 Radiobinding of 251-labelled 5T4 monoclonal antibody
to StMPM membrane protein bound to microtitre plates. Doubl-
ing dilutions of either normal human or goat serum with (A, *)
or without (A, 0) soluble StMPM respectively. The human and
goat serum was at a final initial concentration of 1/100.94 P.J. SOUTHALL et al.
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Figure 2 Avidin-biotin peroxidase staining of 5T4 mAb in cryos-
tat sections of (a) squamous carcinoma of the lung ( x 96); (b)
invasive breast carcinoma ( x 96); (c) adenocarcinoma of the
endometrium x 240) and (d) squamous carcinoma of the cervix
( x 96).
Figure 3 Avidin-biotin peroxidase staining of 5T4 mAb in cryos-
tat sections of (a) complete hydatidiform mole ( x 60); (b)
choriocarcinoma showing strong labelling of syncytiotrophoblast
membrane ( x 96) and (c) placental site trophoblast tumour
showing strong membrane labelling and faint cytoplasmic reac-
tivity ( x 150).
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the differentiating immunohistochemical features are sum-
marised below.
In contrast to antibodies directed against HCG and UGP
(Kardana et al., 1988) 5T4 antibody gives intense reactions
with syncytiotrophoblast of term placenta. Seminomas,
usually positive with mAbs against the Nalgao isozyme of
PLAP (e.g. H17/E2, (Epenetos et al., 1984), were almost all
negative using mAb 5T4. The one case that showed some
positivity was a seminoma containing syncytiotrophoblast
giant cells, admixed with embryonal carcinoma. In contrast
to mAbs reactive with the Regan isoenzyme of PLAP (John-
son, 1984) 5T4 mAb was usually negative with bronchiolar
epithelium. Unlike both 18A/C4 and 18B/A5 antibodies mAb
5T4 did not react with villous cytotrophoblast (Loke et al.,
1986).
From the immunohistochemical profile, it appears that 5T4
mAb recognises an antigen with a restricted normal tissue
distribution, but is reactive with a wide range of tumours.
Our preliminary studies indicate that there is probably less
than 10 ng ml-' of 5T4 antigen in normal or pregnant
human serum. This is based on the fact that antigen was
detectable in 1 jug ml-' of StMPM and that 5T4 antigen
purified to homogeneity represents at most 0.001% of the
protein in N-40-solubilised StMPM. The purification used
WGA and 5T4 affinity chromatography with 10,000 enrich-
ment and up to 70% yield (Hole & Stern, 1990). Thus, the
assay could detect at least 0.1 ng of 5T4 ml-'. Since the
highest concentration of serum which showed acceptable
non-specific inhibition was a 10-2 dilution, the upper limit
for antigen is 10 ng ml-'. These results contrast with changes
in expression of PLAP detected, during pregnancy with in-
creasing concentrations to a level of pg ml-' at term (John-
son, 1984) and in patients with either ovarian or testicular
cancer or trophoblastic disease (Epenetos et al., 1985;
McLaughlin et al., 1983). In spite of the presence of cir-
culatory antigen, some antibodies have been successfully used
in radioimaging of tumours (Baldwin & Byen, 1987). How-
ever, other antibodies have shown poor efficacy in uptake in
vivo with circulating antigen present (Martin & Halpern,
1986; Pedley et al., 1988). Therefore, detection of a memb-
rane antigen may offer significant advantages in radioim-
munoscintigraphy and therapy. The development of a solid
phase capture assay to achieve higher levels of sensitivity
comparable with PLAP assays (McLaughlin et al., 1983)
(0.07 ng ml-') will be necessary to measure the precise levels
of antigen in serum from patients with different malignancies.
The antibody is currently being assessed for targeting in
selected patients.
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